Skip to main content

Biobase to Integrate, Co-Market Database With GNI's Cellular-Imagining Software

NEW YORK (GenomeWeb News) — Biobase will integrate its database with GNI’s cellular-imaging software and continue to develop and market the products, GNI said today.
 
Biobase will develop an interface between its databases, which are designed for gene regulation, signal transduction, and proteomics research, with GNI’s Cell Illustrator 3.0 software, which allows researchers to “create computer images and simulations of complete metabolic and gene regulatory pathways, signal transduction cascades and dynamic interactions.”
 
The combination “should provide users of the Cell Illustrator with easier access to pathway information and the ability to use the simulation function,” according to GNI.
 
It will be marketed to pharmaceutical companies, which GNI said will be able to “input their own research data, analyze gene networks with their own personal computers and carry out model analysis based on pathways.”
 
Pharmaceutical customers will be able to share research content and perform final experiments based on results from simulated tests, GNI said.
 
Biobase is headquartered in Germany. GNI is based in Tokyo.

Filed under

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.